Vorasidenib

Vorasidenib


Vorasidenib is an orally bioavailable, brain-penetrant inhibitor of mutant isocitrate dehydrogenase-1 and -2, suppressing oncometabolite D-2-hydroxyglutarate generation with nanomolar potency to treat isocitrate dehydrogenase–mutant diffuse gliomas.

Molecular structure of the compound BP-44064
    • Unit
    • Price
    • Qty
    • 25 MG
    • $120.00
    • 50 MG
    • $210.00
    • 100 MG
    • $320.00
    • 250 MG
    • $540.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire